Sehat to Conduct Nationwide Survey for Dengue Vaccination

After much debate on the availability of the dengue vaccine in Pakistan, Sehat has taken a huge step by planning to conduct a nationwide survey that takes into account how many people are actually interested in receiving the vaccine.

You can express your interest in receiving the vaccine through filling out this form. Sehat will then notify you on when it is available for purchase.

The vaccine has been approved in the following countries: 

  • Mexico
  • Philippines
  • Brazil
  • El Salvador
  • Costa Rica
  • Paraguay
  • Guatemala
  • Peru
  • Indonesia
  • Thailand
  • Singapore

However, there have been issues with customs and the concerned regulatory authorities regarding its approval and its entry in to the market in Pakistan.

Denue is a life-threatening disease that is caused by the Aedes Aegypti mosquito, with around 100 million registered cases occurring every year. The incubation period (timeframe in which victim shows symptoms) varies from 2 days to 14 days.

If the person in question has indeed contracted dengue, severe pain in joints and muscles ensues (which gives dengue fever the alternate name of break-bone fever), as does a headaches and a rash similar to the one contracted from measles

High fever normally is contracted, with body temperature exceeding 104 degrees Celcius. Medicinal treatment includes prolonged use of a painkiller, while an alternate treatment involves ingestion of a papaya-leaf based infusion.

40 dengue cases were detected in Rawalpindi in November 2016, while 17 cases were reported in Karachi in January of this year. A few months ago, it was reported that 80% of reported dengue cases in Lahore originated from the posh DHA Housing Society. Over 2,000 have been detected in KPK alone ever since 2015.

However, prevention is always better than the cure in the realm of infectious diseases. That’s where Sehat enters the picture to ensure that when the vaccine will be made available in Pakistan, it will notify respondents through a survey and will have the ability to send the vaccine to their doorstep.